High-purity GHRP-6 is available for laboratory research applications requiring strict analytical verification and lot-to-lot consistency. PX1 Research supplies USA-manufactured research compounds accompanied by comprehensive third-party Certificates of Analysis (COAs), RP-HPLC purity reports, and mass spectrometry verification.
High-purity GHRP-6 is available for laboratory research applications requiring strict analytical verification and lot-to-lot consistency. PX1 Research supplies USA-manufactured research compounds accompanied by comprehensive third-party Certificates of Analysis (COAs), RP-HPLC purity reports, and mass spectrometry verification.
Laboratories looking to buy GHRP (Growth Hormone Releasing Peptide) compounds require high-purity, analytically verified reagents to ensure reproducible experimental results. PX1 Research provides research-grade GHRP-6 synthesized in GMP-compliant USA facilities, backed by ISO 17025 third-party COAs detailing RP-HPLC purity (>99%) and mass spectrometry identity verification for in vitro and animal model research.
When purchasing synthetic peptides for experimental assays, selecting a verified supplier is critical to eliminate confounding factors such as residual trifluoroacetic acid (TFA), organic solvents, structural truncation, or bacterial endotoxin contamination. Investigators evaluating the growth hormone secretagogue pathway can explore our full catalog of verified reagents via the all peptides inventory or consult our technical resource database at the PX1 research library.
To ensure internal validity across biochemical, cellular, and physiological research protocols, investigators must enforce strict quality standards when sourcing synthetic secretagogues. Low-purity peptide batches frequently exhibit variable binding kinetics, unpredictable degradation rates, or uncharacteristic cytotoxic artifacts in cell culture models.
PX1 Research establishes rigorous benchmark specifications for every manufactured lot of GHRP-6. Laboratory buyers should verify that candidate lots satisfy key analytical metrics prior to assay integration:
1. Purity Verification: Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) analysis confirming a single predominant peak corresponding to ≥99.0% chemical purity. 2. Molecular Identity: Electrospray Ionization Mass Spectrometry (ESI-MS) confirming exact theoretical monoisotopic mass without truncation or adduct formations. 3. Endotoxin Quantitation: Chromogenic Limulus Amebocyte Lysate (LAL) testing guaranteeing endotoxin levels strictly below <0.1 EU/mg. 4. Residual Solvent Analysis: Headspace Gas Chromatography (GC-MS) ensuring complete removal of synthesis reagents and volatile organic contaminants. 5. Lot Traceability & Logistics: USA-manufactured stock stored under climate-controlled conditions with same-day shipping (Monday–Friday) dispatching directly from California and Arizona facilities.
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide with the amino acid sequence His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 and a molecular weight of 873.01 g/mol. As one of the early synthetic ghrelin mimetics, GHRP-6 selectively targets the growth hormone secretagogue receptor (GHS-R1a), a 7-transmembrane G-protein coupled receptor expressed primarily in the anterior pituitary gland and hypothalamus.
In vitro receptor binding assays demonstrate that GHRP-6 activates GHS-R1a independently of endogenous Growth Hormone Releasing Hormone (GHRH). Upon binding, the receptor triggers a conformational change that stimulates the phospholipase C (PLC) signal transduction cascade. This leads to inositol trisphosphate (IP3) accumulation and rapid intracellular calcium mobilization from the endoplasmic reticulum, culminating in exocytotic release of growth hormone from somatotroph cells.
Detailed signaling pathway data and receptor-ligand kinetics for the growth hormone axis are documented in our dedicated guide to growth hormone secretagogues.
In structural and functional studies, researchers frequently compare GHRP-6 against alternative secretagogues to assess potency profiles, receptor selectivity, and downstream hormonal cross-reactivity. Understanding these functional distinctions assists research teams in selecting the optimal peptide sequence for specific experimental paradigms.
Compared to second- and third-generation secretagogues like GHRP-2 and Ipamorelin, GHRP-6 demonstrates distinct physiological signaling characteristics in animal models. While GHRP-2 exhibits higher potency in stimulating pituitary GH secretion in rodent assays, it also produces slightly greater co-stimulation of adrenocorticotropic hormone (ACTH) and prolactin. Conversely, Ipamorelin represents a highly selective agonist with negligible affinity for ACTH or prolactin pathways.
GHRP-6 is also uniquely distinguished by its profound activation of hypothalamic neuropeptide Y (NPY) and agouti-related protein (AgRP) neurons via central ghrelin receptors. This secondary neural activation drives marked hyperphagic behavior in rodent models, making GHRP-6 an ideal positive control in metabolic, orexigenic, and cachexia research. For investigations combining receptor mimetics with GHRH agonists, researchers frequently study co-administration protocols involving CJC-1295 No DAC or Sermorelin to evaluate synergistic GH release.
Preclinical studies indicate that GHRP-6 serves as a versatile tool across multiple specialized areas of biomedical research, ranging from cellular metabolism to tissue cytoprotection.
Metabolic and Appetite Regulation: Animal models demonstrate that central and peripheral administration of GHRP-6 increases food intake through hypothalamic NPY/AgRP axis stimulation. Investigators utilize the compound to probe central neural circuits governing nutrient sensing, energy expenditure, and lipid accumulation.
Gastrointestinal Motility: Because GHS-R1a receptors are widely expressed throughout the enteric nervous system, in vitro and organ-bath preparations show that GHRP-6 enhances smooth muscle contractility and gastric emptying. This mechanism is frequently studied in models of post-operative ileus and diabetic gastroparesis.
Cardioprotection and Cytoprotection: In rodent models of myocardial ischemia-reperfusion injury, preclinical data suggest that GHRP-6 exerts direct tissue-protective effects independent of GH release. The peptide appears to attenuate oxidative stress, downregulate pro-inflammatory cytokines, and reduce apoptotic cascades in cardiomyocyte cultures.
Proper reconstitution technique is vital for maintaining the physical integrity and concentration accuracy of GHRP-6 solutions in research environments. Synthetic hexapeptides are vulnerable to enzymatic cleavage, mechanical shear stress, and surface adsorption if handled improperly.
To reconstitute lyophilized GHRP-6, technicians should sanitize the rubber stopper of the vial using a 70% isopropyl alcohol swab and allow it to air-dry completely in a laminar flow hood. Using a sterile laboratory syringe, introduce an appropriate volume of Bacteriostatic Water (0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS, pH 7.4), directing the liquid stream down the glass wall of the vial rather than directly onto the lyophilized cake.
Allow the diluent to gently hydrate the peptide cake without vigorous shaking. Swirl the vial with a slow, gentle circular motion until the lyophilized powder is fully dissolved into a clear, colorless solution. Forceful agitation or vortexing must be avoided, as hydrophobic regions within the peptide chain can aggregate or denature under turbulent physical stress.
Maintaining correct temperature and environmental controls is essential to preserve the structural stability of synthetic peptides over extended experimental timelines. Unreconstituted, lyophilized GHRP-6 supplied by PX1 Research is stable at ambient room temperature during short-term transit, but long-term laboratory storage demands controlled sub-zero environments.
For storage durations exceeding 30 days, sealed vials containing lyophilized GHRP-6 should be maintained at -20°C or -80°C in a non-frost-free freezer to prevent thermal degradation and moisture absorption. Under sub-zero desiccated conditions, the lyophilized peptide retains potency for up to 24 months.
Once reconstituted into aqueous liquid solution, the peptide must be stored at 2°C to 8°C (refrigerated) and used within 30 days. For long-term storage of reconstituted stock solutions, aliquot the liquid into single-use polypropylene microtubes and freeze at -80°C to eliminate repetitive freeze-thaw cycles, which physically degrade peptide bonds.
PX1 Research supports university departments, pharmaceutical laboratories, and contract research organizations (CROs) requiring reliable volume sourcing of analytical-grade secretagogues. Institutional accounts benefit from dedicated support, batch-reserved lots, and customized analytical documentation packages.
Organizations planning large-scale, multi-stage, or longitudinal preclinical studies can submit volume quote requests directly through our wholesale ordering hub. Bulk orders undergo identical analytical verification—including lot-specific RP-HPLC chromatography and ESI-MS spectrographic profiling—ensuring complete continuity between initial screening phases and full-scale experimental runs.
Where can accredited institutions buy GHRP compounds for laboratory research?
Accredited research institutions, universities, and private laboratories can buy GHRP compounds directly from PX1 Research. All peptides are manufactured in US-based GMP-compliant facilities and accompanied by lot-specific third-party COAs confirming identity and purity.
What analytical testing validates the purity of PX1 Research GHRP-6?
Every lot of GHRP-6 undergoes high-performance liquid chromatography (RP-HPLC) for chemical purity verification (target ≥99%) and electrospray ionization mass spectrometry (ESI-MS) for absolute molecular weight confirmation. Endotoxin levels are measured via chromogenic LAL assays.
How does GHRP-6 differ structurally and functionally from GHRP-2 and Ipamorelin?
GHRP-6 is a synthetic hexapeptide that strongly activates the GHS-R1a receptor and stimulates central ghrelin pathways driving orexigenic (appetite) signaling. GHRP-2 exhibits higher potency for GH release but slightly greater cortisol/prolactin co-stimulation, while Ipamorelin offers selective GH release with minimal appetite or secondary hormone stimulation.
What is the standard protocol for reconstituting lyophilized GHRP-6 in a lab setting?
Reconstitute GHRP-6 under sterile laminar flow by adding bacteriostatic water or sterile PBS along the inner glass wall of the vial. Gently swirl until fully dissolved. Avoid vortexing or violent shaking to prevent mechanical denaturation.
How should reconstituted GHRP-6 solutions be stored to preserve peptide stability?
Reconstituted GHRP-6 solutions should be kept refrigerated at 2°C to 8°C and used within 30 days. For longer storage, aliquot into single-use sterile microcentrifuge tubes and freeze at -80°C to prevent degradation from repetitive freeze-thaw cycles.
What endotoxin threshold does PX1 Research maintain for research peptides?
PX1 Research enforces a strict endotoxin limit of <0.1 EU/mg for all research-grade peptide lots, verified through chromogenic Limulus Amebocyte Lysate (LAL) testing to prevent cell-culture toxicity or confounding inflammatory responses in animal models.
Is GHRP-6 suitable for human consumption or clinical administration?
No. GHRP-6 is supplied strictly as a research chemical intended exclusively for in vitro laboratory assays, biochemical testing, and non-human animal research. It is not approved for clinical, therapeutic, diagnostic, or human dietary use.
What shipping options are available for GHRP-6 orders?
PX1 Research provides same-day dispatch for orders placed Monday through Friday before 3:00 PM PST. Shipments originate directly from climate-controlled fulfillment facilities in California and Arizona using expedited carrier options.
Can laboratories request bulk custom synthesis or wholesale volumes of GHRP-6?
Yes. Institutional buyers and laboratories requiring bulk quantitates or batch-reserved inventory can place bulk requests through the PX1 Research wholesale hub for custom volume quotes and reserved analytical lots.
How does GHRP-6 interact with the growth hormone secretagogue receptor (GHS-R1a)?
GHRP-6 functions as a full agonist at the GHS-R1a receptor, stimulating the intracellular IP3/DAG signaling pathway. This induces intracellular calcium influx in pituitary somatotrophs, triggering pulsatile endogenous growth hormone secretion.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.